![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright © 2001 European Molecular Biology Organization A plastid segregation defect in the protozoan parasite Toxoplasma gondii Department of Biology, 305 Goddard Laboratories and 1Cancer Center Flow Cytometry Shared Resource, University of Pennsylvania, Philadelphia, PA 19104, USA 2Present address: Center for Tropical and Emerging Global Diseases, and Department of Cellular Biology, University of Georgia, Athens, GA 30602, USA 3Corresponding author e-mail: droos/at/mail.sas.upenn.edu Received November 9, 2000; Revised December 6, 2000; Accepted December 6, 2000. This article has been cited by other articles in PMC.Abstract Apicomplexan parasites—including the causative agents of malaria (Plasmodium sp.) and toxoplasmosis (Toxoplasma gondii)—harbor a secondary endosymbiotic plastid, acquired by lateral genetic transfer from a eukaryotic alga. The apicoplast has attracted considerable attention, both as an evolutionary novelty and as a potential target for chemotherapy. We report a recombinant fusion (between a nuclear-encoded apicoplast protein, the green fluorescent protein and a rhoptry protein) that targets to the apicoplast but grossly alters its morphology, preventing organellar segregation during parasite division. Apicoplast-deficient parasites replicate normally in the first infectious cycle and can be isolated by fluorescence-activated cell sorting, but die in the subsequent host cell, confirming the ‘delayed death’ phenotype previously described pharmacologically, and validating the apicoplast as essential for parasite viability. Keywords: Apicomplexa/apicoplast/delayed death phenotype/organelle segregation/Plasmodium falciparum Introduction The protozoan phylum Apicomplexa includes many important human and veterinary pathogens, responsible for a wide variety of diseases (Levine, 1988). Plasmodium sp. are the causative agents of malaria (Persidis, 2000), Toxoplasma gondii is a serious congenital infection in humans and sheep (Dubey and Welcome, 1988; Roizen et al., 1995), and both T.gondii and Cryptosporidium parvum are prominent opportunistic pathogens associated with AIDS (Luft and Remington, 1992; Luft et al., 1993). Other apicomplexan parasites infect animals as diverse as cattle, poultry and shellfish, with severe economic impact. Among the Apicomplexa, molecular genetic systems have been developed only for Toxoplasma and Plasmodium; of these, T.gondii provides the more accessible system for ultrastructural analysis (Roos et al., 1999a). Considerable effort has been invested in devising effective drug treatments for these pathogens, and such studies have gained renewed impetus due to the emergence and spread of drug resistance (Ricketts and Pfefferkorn, 1993; White, 1998; Warhurst, 1999), and therapeutic complications associated with the chronic treatment of AIDS patients (Haberkorn, 1996). The recent discovery of an unexpected organelle—a non-photosynthetic plastid designated the apicoplast—in Toxoplasma, Plasmodium and other apicomplexan parasites has opened a new realm for identifying potential drug targets (Fichera and Roos, 1997; Waller et al., 1998; Jomaa et al., 1999; McFadden and Roos, 1999). These studies have also raised fascinating biological questions as to the origin and function(s) of this unusual organelle (Wilson et al., 1996; Köhler et al., 1997; McFadden and Waller, 1997; Roos et al., 1999b). The apicomplexan plastid is thought to have arisen by ‘secondary endosymbiosis’, when the ancestor of these parasites engulfed a eukaryotic alga, and retained the (endosymbiotic) algal plastid (Palmer and Delwiche, 1996; Köhler et al., 1997; McFadden et al., 1997; Blanchard and Hicks, 1999; Dzierszinski et al., 1999). Both the phylogeny of the apicoplast genome and the structure of this organelle (surrounded by four membranes) support this hypothesis (McFadden and Roos, 1999). Pharmacological studies suggest that the apicoplast is the target for a variety of antibiotics commonly thought of as antibacterial agents (macrolides, lincosamides, rifamipicins, fluoroquinolones, etc.; Fichera and Roos, 1997). All of these drugs exhibit peculiar kinetics of cell killing: parasite replication is only inhibited after invasion of the subsequent host cell after initiation of treatment (Pfefferkorn et al., 1992; Fichera et al., 1995). Such observations have led to speculation that the apicoplast may be required for the establishment of a functional parasitophorous vacuole, the specialized structure inside infected cells within which parasites replicate until host cell lysis (Suss-Toby et al., 1996; Lingelbach and Joiner, 1998). The mechanistic basis of this ‘delayed death phenotype’ remains unexplained. Although the apicoplast genome encodes no metabolic enzymes, mining the Plasmodium falciparum genome and T.gondii expressed sequence tag (EST) databases (Ajioka, 1998; Bowman et al., 1999; Gardner, 1999) has identified numerous nuclear-encoded apicoplast genes, implicating this organelle in the biosynthesis of fatty acids and terpenoids (Waller et al., 1998; Jomaa et al., 1999; Roos et al., 1999b). Nuclear-encoded apicoplast proteins are characterized by a bipartite N-terminal sequence, which is both necessary and sufficient for targeting to the organelle (Waller et al., 1998). The extreme N-terminus consists of a secretory signal sequence, mediating co-translational translocation into the endoplasmic reticulum; the subterminal domain functions as a plastid transit peptide (Roos et al., 1999b; Waller et al., 2000). In combination, these domains provide a remarkable scheme for targeting proteins across the multiple membranes surrounding the apicoplast. In the course of studies on apicoplast targeting, we inadvertently generated a fusion protein, which produces a surprising phenotype: mis-segregation of the apicoplast during parasite replication. These mutant parasites provide a cell biological confirmation of the ‘delayed death’ phenotype, validate the apicoplast as a target for drug development, and provide useful tools for dissecting the function of this intriguing organelle. Results A recombinant plastid–rhoptry–GFP fusion protein perturbs apicoplast morphology We have previously demonstrated that a fusion between the nuclear-encoded apicoplast acyl-carrier protein (ACP) and the green fluorescent protein (GFP) results in targeting of the GFP reporter into the apicoplast in living parasites (Waller et al., 1998), as shown in Figure 1
In order to study targeting sequences involved in the import of proteins into the apicoplast, we have generated a variety of constructs based on the ACP–GFP reporter. In one such construct, a truncated fragment of ROP1 containing rhoptry targeting sequences (Soldati et al., 1998) was inadvertently retained at the C-terminus of ACP–GFP (see Materials and methods). Transient transfection with this construct (ACP–GFP–mROP1) resulted in an unusual pattern of fluorescence, often appearing as a large, ring-like structure (Figure 1 To determine whether this ring-like structure is indeed the apicoplast, we turned to electron microscopic analysis. The morphology of the parasite nucleus, mitochondrion, Golgi, rhoptries, micronemes, dense granules, etc. appears normal in ACP–GFP–mROP1-transfected parasites, but these studies revealed very unusual apicoplast architecture, as shown in Figure 2
Transient expression of ACP–GFP–mROP1 inhibits apicoplast segregation Each T.gondii tachyzoite establishes an independent para sitophorous vacuole upon host cell invasion (Suss-Toby et al., 1996; Lingelbach and Joiner, 1998), and mitotic replication proceeds synchronously, producing 2, 4, 8, … parasites within a single vacuole (Ogino and Yoneda, 1966; Fichera et al., 1995), ultimately lysing the host cell. The observation of only a single apicoplast per vacuole in parasites expressing ACP–GFP–mROP1 (cf. Figures 1
Several experiments were carried out to confirm that transfection with the ACP–GFP–mROP1 construct results in mis-segregation of the entire apicoplast organelle (rather than the ACP–GFP–mROP1 reporter protein alone). Exploiting the ability to visualize multiple fluorescent proteins simultaneously in living cells, stable parasite transgenics expressing ACP–GFP in the apicoplast (Waller et al., 1998) were transfected with an ACP–red fluorescent protein (RFP)–mROP1 fusion construct (Figure 4
In a further experiment, parasites were fixed and stained with 4′,6-diamidino-2-phenylindole (DAPI) (Figure 4 Stable transgenic parasites expressing GFP in the apicoplast, rhoptries or other organelles are readily isolated (cf. Figure 1 Apicoplast segregation mutants confirm that this is an essential organelle and validate the ‘delayed death’ phenotype The ability of parasites without an apicoplast to grow and divide (cf. Figure 3 Parasites stably expressing ACP–GFP were transiently transfected with the ACP–GFP–mROP1 construct and permitted to infect host cells. Despite mis-segregation of the apicoplast, these parasites replicated normally, ultimately lysing the host cell monolayer as rapidly as controls (data not shown). Extracellular parasites were then harvested and fractionated using a fluorescence-activated cell sorter (FACS). The GFP fluorescence profile reveals three populations (Figure 5
FACS-sorted parasites from each of these populations were inoculated into fresh host cell cultures, and assayed for invasion, ACP expression/localization, intracellular growth rates and plaque-forming ability (Figure 6
‘Super-bright’ parasites (green circles) were able to grow and lyse out from their host cells, but contained only a single large apicoplast (central micrograph), just as seen for transfected parasites in the first infectious cycle (Figure 3 ‘Dark’ parasites invaded the host cell monolayer as efficiently as wild type, but showed no intracellular fluorescence (right-hand micrograph), grew very slowly and eventually died (blue diamonds). Initial doubling times were ~26.1 h, but growth slowed thereafter. These parasites never produced vacuoles containing >16 tachyzoites, never managed to lyse the host cells and never produced plaques. The death of plastid-deficient parasites in this second infectious cycle confirms the ‘delayed death’ phenotype observed when the apicoplast is eliminated by pharmacological means (Fichera and Roos, 1997; Sullivan et al., 2000). Discussion In the course of studies on apicoplast targeting and purification in the protozoan parasite T.gondii, we generated a fusion construct containing the apicoplast protein ACP, the fluorescent protein reporter GFP and a fragment of the rhoptry protein ROP1 (ACP–GFP–mROP1). Expression of this recombinant ‘poison’ protein in transiently transfected T.gondii tachyzoites results in specific targeting to the apicoplast, but produces an unusual phenotype: grossly aberrant apicoplast morphology, containing numerous complicated inclusions (Figures 1 Apicoplast segregation mutants Wild-type parasites contain only a single apicoplast per cell (Köhler et al., 1997). Failure of the apicoplast to divide during parasite replication therefore means that the organelle is partitioned into only one of the two daughter cells formed during mitosis, one of the four granddaughters, etc. (Striepen et al., 2000). Both apicoplast-containing and -deficient parasites continue to replicate within the parasitophorous vacuole (Figure 3 The ability to express GFP in T.gondii transgenics, to target this reporter to the apicoplast (Waller et al., 1998) and to isolate GFP-expressing parasites by FACS (Striepen et al., 1998) facilitates examination of apicoplast segregation mutants in living parasites (Figure 5 The mechanism of apicoplast mis-segregation The ROP1 protein (which constitutes the C-terminal portion of the ACP–GFP–mROP1 construct responsible for apicoplast mis-segregation) exhibits several interesting characteristics, behaving as a soluble protein within the rhoptries, but rapidly associating with membranes after secretion (Saffer et al., 1992). The predicted amino acid sequence of ROP1 contains no obvious transmembrane domains, but exhibits weak similarity to rat salivary gland proteins involved in protein complex assembly (Ossorio et al., 1992). It is possible that fusion of this protein to ACP–GFP (which on its own is efficiently targeted to the apicoplast; Waller et al., 1998) prevents complete translocation across the multiple membranes surrounding the apicoplast (McFadden and Roos, 1999; Roos et al., 1999b). Consistent with this interpretation, immunolocalization typically reveals a peripheral staining pattern (Figure 2 Precisely how expression of ACP–GFP–mROP1 causes the dramatic changes observed in apicoplast morphology remains unknown. It is possible that getting stuck during translocation across the apicoplast membranes interferes with import mechanisms (although the import and processing of native ACP appear normal in parasites expressing ACP–GFP–mROP1 and retaining the plastid; not shown). Import of the ACP domain of the fusion protein could result in internalization of apicoplast membranes into the organelle in association with the mROP1 domain, producing the membranous inclusions observed by electron microscopy (Figure 2 Disruption of apicoplast segregation may be a consequence of the presence of multiple large inclusions within the organelle (Robertson et al., 1995). The apicoplast is closely associated with the centriole in the apical juxtanuclear region of parasite cells (Striepen et al., 2000). The centriole divides early in the mitotic process, and the apicoplast becomes elongated as the two daughter centrioles migrate to opposite sides of the nucleus, associated with the ends of the intranuclear spindle. Anchored to the centrioles, the apicoplast is ‘cut’ in two (without any obvious fission ring) by the microtubule-dependent growth of daughter parasite pellicles within the mother. Time-lapse imaging of parasites expressing ACP–GFP–mROP1 reveals early stages of apicoplast elongation in dividing parasites (Figure 3 ACP–GFP–mROP1 expression peaks ~20 h after transient transfection, declining as the non-replicating plasmid is diluted and/or degraded. Inhibition of apicoplast segregation is maintained for many days, however, presumably because it is difficult to restore normal morphology to a mutant organelle. As noted above, apicoplast-deficient parasites die in the second host cell, while those that retain an apicoplast survive and divide, with the organelle growing larger and larger (Figure 3 The primary effects of ACP–GFP–mROP1 expression appear to be restricted to the apicoplast. The morphology and segregation of other organelles are normal (Figure 2 The ‘delayed death’ phenotype and function of the apicoplast Growth assays performed on parasites in which the apicoplast has been inactivated by pharmacological treatment reveal a peculiar kinetics of cell death, in which parasites do not die until after entering the second host cell following drug treatment (Fichera et al., 1995; Sullivan et al., 2000). The apicoplast segregation mutants provide a completely independent cell biological validation of this ‘delayed death phenotype’. Apicoplast-deficient cells expressing ACP–GFP–mROP1 replicate normally in the first host cell, but the growth of FACS-sorted dark parasites slows immediately upon entry into a second host cell. Meanwhile, their green, apicoplast-containing sisters replicate nearly as rapidly as wild-type parasites. The observation that parasite replication is slowed only upon entry into the next host cell after loss of the apicoplast (induced by either pharmacological or cell biological means) suggests that the apicoplast may be required for establishment of the parasitophorous vacuole. Apicoplast-deficient parasites are clearly capable of parasitophorous vacuole formation (Figure 6 The ability to isolate plastid-deficient and ‘super-apicoplast’-containing parasites provides useful reagents for the further characterization of this organelle, including organelle purification, analysis by two-dimensional gel electrophoresis, mass spectroscopy, etc. These reagents are also very helpful for functional studies. For example, the inability of plastid-deficient parasites to proliferate in host cells co-infected with wild-type parasites demonstrates that apicoplast function cannot operate in trans (not shown). Preliminary experiments also indicate that treatment of apicoplast-deficient parasites with ciprofloxacin or clindamycin (antibiotics that specifically target apicoplast DNA and protein synthesis; Fichera and Roos, 1997) fails to exacerbate replication defects observed in the second host cell, providing an assay for testing the function of drugs thought to target the apicoplast specifically. Much current research is devoted to mining of the T.gondii EST and P.falciparum genome databases, with an eye towards identifying nuclear-encoded apicoplast proteins required for the metabolic functions of this organelle (Waller et al., 1998; Jomaa et al., 1999). Comparing apicoplast-containing parasites with apicoplast-deficient mutants will greatly facilitate the analysis of potential metabolic pathways associated with the apicoplast. Materials and methods Parasites and host cells The RH strain of T.gondii tachyzoites was maintained by serial passage in human foreskin fibroblast (HFF) cell monolayers, and plaque assays were carried out as previously described (Roos et al., 1994). To measure the growth rate of intracellular parasites (Fichera et al., 1995), confluent monolayers grown on 1 cm #1 glass coverslips in 24-well plates were inoculated with 2 × 104 parasites/well. After incubation at 37°C for 2 h to allow parasite invasion, cultures were rinsed with fresh medium to remove extracellular parasites. One coverslip was then fixed and stained with anti-ACP (Waller et al., 1998) every 12 h. Parasite growth was assayed by counting the number of parasites per parasitophorous vacuole for at least 50 vacuoles from multiple, randomly selected fields on each coverslip, and the presence/absence of ACP was monitored in parallel. Averages and standard errors were calculated for each sample at each time point (Zar, 1996). Molecular methods Plasmids ACP–GFP and ROP1–GFP have been described previously (Striepen et al., 1998; Waller et al., 1998). The ACP–GFP–mROP1 fusion was made by inserting a myc epitope tag followed by sequences encoding ROP1 amino acids 139–338 (the rhoptry targeting domain of this 389 amino acid protein) downstream of GFP coding sequences in the ACP–GFP plasmid. Fifty micrograms of plasmid DNA (Qiagen Maxi-preps) and 107 freshly lysed-out tachyzoites were used for each transfection, using previously described protocols (Roos et al., 1994). In transient assays, fusion protein expression was typically examined 24 h post-transfection. Stable transformants were selected in the presence of 20 µM chloramphenicol (for plasmids expressing CAT) or by co-transfection with plasmid pDHFR-TSc3 (Donald and Roos, 1993) and selection in 1 µM pyrimethamine. Light microscopy GFP, RFP, fluorescein isothiocyanate (FITC) and DAPI fluorescence were detected using a Zeiss Axiovert 35 inverted microscope equipped with a 100 W Hg-vapor lamp. For immunofluorescence assays, parasites were fixed with 3.7% paraformaldehyde, permeabilized with 0.25% Triton X-100 and blocked with 1% bovine serum albumin in phosphate-buffered saline (PBS) pH 7.4 at room temperature. GFP was detected using a polyclonal antiserum (Clontech; 1:500 dilution) followed by FITC-conjugated goat anti-rabbit IgG (Sigma; 1:160). Apicoplast DNA was visualized by staining with DAPI (Molecular Probes). The growth and division of parasites were monitored by video-enhanced microscopy using a digital CCD camera (Hamamatsu). For long-term observation of living samples, parasites and monolayers were maintained at 37°C using a ΔTC3 culture dish system (Bioptechs). Neutral pH was maintained by addition of 10 mM HEPES pH 7.4 (GIBCO-BRL) to the culture medium. In time-lapse experiments, both fluorescence and phase images were taken every 5 min, using an automated program (Openlab; Improvision). Electron microscopy Infected cells were fixed in situ with a freshly prepared mixture containing 1% glutaraldehyde (8% stock; Electron Microscopy Sciences) and 1% OsO4 in 50 mM phosphate buffer pH 6.2. Fixative was added at room temperature and samples placed on ice for 45 min. Samples were then rinsed with distilled water to remove excess phosphate, released from the plastic substratum by gentle scraping, pelleted, and stained with 0.5% aqueous uranyl acetate for 6–16 h at 4°C. Following dehydration in acetone and embedding in Epon–Araldite, ultra-thin sections (50–70 nm) were cut and stained with uranyl acetate and lead citrate, and examined using a Philips 200 electron microscope. For immunoelectron microscopy, infected cells were fixed in situ with a mixture of 4% formaldehyde and 0.5% glutaraldehyde in 100 mM phosphate buffer pH 7.0 for 1–2 h at 4°C, harvested by scraping, pelleted, dehydrated through increasing concentrations of ethanol to 70% and embedded in LR White (Electron Microscopy Sciences). Polymerization was carried out at 37°C for 5 days. Sections (50–70 nm) were cut and mounted on uncoated nickel grids. Sections were incubated with anti-GFP (Seedorf et al., 1999; diluted 1:100 in PBS–glycine), followed by a goat anti-rabbit IgG conjugated to 5 nm gold particles (British BioCell International; 1:100 dilution). Sections were stained with 1% uranyl acetate in 30% methanol and examined as above. Flow cytometry Freshly lysed-out tachyzoites were filtered through 3 µm pore size polycarbonate filters (Nuclepore) and centrifuged at 1500 g for 15 min. The parasite pellet was then resuspended in culture medium, counted using a hemocytometer and adjusted to 5 × 106 parasites/ml. FACS assays were performed on a FACStar Plus cell sorter (Becton Dickinson) equipped with CELLQUEST software. Acknowledgements We wish to thank Andrew Morschauser and Richard Schretzenmair for help with FACS analysis, Ross F.Waller for providing anti-ACP antibodies, John M.Murray and Helen L.Compton for helpful advice, and Martin Fraunholz and Stuart Ralph for critical reading of the manuscript. This work was supported by grants from the NIH; D.S.R. is a Burroughs Wellcome Scholar in Molecular Parasitology. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
J Protozool. 1988 Nov; 35(4):518-20.
[J Protozool. 1988]Nat Biotechnol. 2000 Jan; 18(1):111-2.
[Nat Biotechnol. 2000]J Am Vet Med Assoc. 1988 Sep 15; 193(6):697-700.
[J Am Vet Med Assoc. 1988]Pediatrics. 1995 Jan; 95(1):11-20.
[Pediatrics. 1995]Clin Infect Dis. 1992 Aug; 15(2):211-22.
[Clin Infect Dis. 1992]Antimicrob Agents Chemother. 1993 Nov; 37(11):2358-63.
[Antimicrob Agents Chemother. 1993]Br Med Bull. 1998; 54(3):703-15.
[Br Med Bull. 1998]Infection. 1999; 27 Suppl 2():S55-8.
[Infection. 1999]Parasitol Res. 1996; 82(3):193-9.
[Parasitol Res. 1996]Nature. 1997 Nov 27; 390(6658):407-9.
[Nature. 1997]Proc Natl Acad Sci U S A. 1996 Jul 23; 93(15):7432-5.
[Proc Natl Acad Sci U S A. 1996]Science. 1997 Mar 7; 275(5305):1485-9.
[Science. 1997]J Eukaryot Microbiol. 1999 Jul-Aug; 46(4):367-75.
[J Eukaryot Microbiol. 1999]J Biol Chem. 1999 Aug 27; 274(35):24888-95.
[J Biol Chem. 1999]Trends Microbiol. 1999 Aug; 7(8):328-33.
[Trends Microbiol. 1999]Int J Parasitol. 1998 Jul; 28(7):1025-31.
[Int J Parasitol. 1998]Nature. 1999 Aug 5; 400(6744):532-8.
[Nature. 1999]Curr Opin Genet Dev. 1999 Dec; 9(6):704-8.
[Curr Opin Genet Dev. 1999]Proc Natl Acad Sci U S A. 1998 Oct 13; 95(21):12352-7.
[Proc Natl Acad Sci U S A. 1998]Science. 1999 Sep 3; 285(5433):1573-6.
[Science. 1999]Proc Natl Acad Sci U S A. 1998 Oct 13; 95(21):12352-7.
[Proc Natl Acad Sci U S A. 1998]Mol Biochem Parasitol. 1998 May 1; 92(2):325-38.
[Mol Biochem Parasitol. 1998]Science. 1993 Nov 5; 262(5135):911-4.
[Science. 1993]Mol Biochem Parasitol. 1998 Oct 30; 96(1-2):37-48.
[Mol Biochem Parasitol. 1998]Science. 1997 Mar 7; 275(5305):1485-9.
[Science. 1997]Science. 1997 Mar 7; 275(5305):1485-9.
[Science. 1997]Trends Microbiol. 1999 Aug; 7(8):328-33.
[Trends Microbiol. 1999]Proc Natl Acad Sci U S A. 1996 Aug 6; 93(16):8413-8.
[Proc Natl Acad Sci U S A. 1996]J Cell Sci. 1998 Jun; 111 ( Pt 11)():1467-75.
[J Cell Sci. 1998]Arch Ophthalmol. 1966 Feb; 75(2):218-27.
[Arch Ophthalmol. 1966]Antimicrob Agents Chemother. 1995 Jul; 39(7):1530-7.
[Antimicrob Agents Chemother. 1995]Proc Natl Acad Sci U S A. 1998 Oct 13; 95(21):12352-7.
[Proc Natl Acad Sci U S A. 1998]Nature. 1997 Nov 27; 390(6658):407-9.
[Nature. 1997]Science. 1997 Mar 7; 275(5305):1485-9.
[Science. 1997]Methods Cell Biol. 1994; 45():27-63.
[Methods Cell Biol. 1994]Nature. 1997 Nov 27; 390(6658):407-9.
[Nature. 1997]Antimicrob Agents Chemother. 1998 Mar; 42(3):715-6.
[Antimicrob Agents Chemother. 1998]Science. 1999 Sep 3; 285(5433):1573-6.
[Science. 1999]Mol Biochem Parasitol. 2000 Jun; 109(1):17-23.
[Mol Biochem Parasitol. 2000]Antimicrob Agents Chemother. 1992 May; 36(5):1091-6.
[Antimicrob Agents Chemother. 1992]Curr Opin Microbiol. 1999 Aug; 2(4):426-32.
[Curr Opin Microbiol. 1999]EMBO J. 2000 Apr 17; 19(8):1794-802.
[EMBO J. 2000]Nature. 1997 Nov 27; 390(6658):407-9.
[Nature. 1997]Mol Biochem Parasitol. 2000 Jun; 109(1):17-23.
[Mol Biochem Parasitol. 2000]Science. 1997 Mar 7; 275(5305):1485-9.
[Science. 1997]J Cell Biol. 2000 Dec 25; 151(7):1423-34.
[J Cell Biol. 2000]J Mol Biol. 1996 Aug 16; 261(2):155-72.
[J Mol Biol. 1996]Proc Natl Acad Sci U S A. 1998 Oct 13; 95(21):12352-7.
[Proc Natl Acad Sci U S A. 1998]Mol Biochem Parasitol. 1998 May 1; 92(2):325-38.
[Mol Biochem Parasitol. 1998]FEBS Lett. 1997 Apr 7; 406(1-2):123-5.
[FEBS Lett. 1997]Nature. 1997 Nov 27; 390(6658):407-9.
[Nature. 1997]Antimicrob Agents Chemother. 1998 Mar; 42(3):715-6.
[Antimicrob Agents Chemother. 1998]J Protozool. 1992 Jul-Aug; 39(4):526-30.
[J Protozool. 1992]Mol Biochem Parasitol. 1992 Jan; 50(1):1-15.
[Mol Biochem Parasitol. 1992]Proc Natl Acad Sci U S A. 1998 Oct 13; 95(21):12352-7.
[Proc Natl Acad Sci U S A. 1998]Trends Microbiol. 1999 Aug; 7(8):328-33.
[Trends Microbiol. 1999]Curr Opin Microbiol. 1999 Aug; 2(4):426-32.
[Curr Opin Microbiol. 1999]J Cell Sci. 1995 Sep; 108 ( Pt 9)():2937-44.
[J Cell Sci. 1995]J Cell Biol. 2000 Dec 25; 151(7):1423-34.
[J Cell Biol. 2000]Antimicrob Agents Chemother. 1995 Jul; 39(7):1530-7.
[Antimicrob Agents Chemother. 1995]Mol Biochem Parasitol. 2000 Jun; 109(1):17-23.
[Mol Biochem Parasitol. 2000]Proc Natl Acad Sci U S A. 1998 Oct 13; 95(21):12352-7.
[Proc Natl Acad Sci U S A. 1998]Science. 1999 Sep 3; 285(5433):1573-6.
[Science. 1999]Nature. 1997 Nov 27; 390(6658):407-9.
[Nature. 1997]Proc Natl Acad Sci U S A. 1998 Oct 13; 95(21):12352-7.
[Proc Natl Acad Sci U S A. 1998]Science. 1999 Sep 3; 285(5433):1573-6.
[Science. 1999]Methods Cell Biol. 1994; 45():27-63.
[Methods Cell Biol. 1994]Antimicrob Agents Chemother. 1995 Jul; 39(7):1530-7.
[Antimicrob Agents Chemother. 1995]Proc Natl Acad Sci U S A. 1998 Oct 13; 95(21):12352-7.
[Proc Natl Acad Sci U S A. 1998]Mol Biochem Parasitol. 1998 May 1; 92(2):325-38.
[Mol Biochem Parasitol. 1998]Proc Natl Acad Sci U S A. 1998 Oct 13; 95(21):12352-7.
[Proc Natl Acad Sci U S A. 1998]Methods Cell Biol. 1994; 45():27-63.
[Methods Cell Biol. 1994]Proc Natl Acad Sci U S A. 1993 Dec 15; 90(24):11703-7.
[Proc Natl Acad Sci U S A. 1993]Mol Cell Biol. 1999 Feb; 19(2):1547-57.
[Mol Cell Biol. 1999]